Učitavanje...
Molecular basis of pharmacotherapies for cognition in Down syndrome
Intellectual disability (ID) in Down syndrome (DS) ranges from low normal to severely impaired, and has a significant impact on the quality of life of the individuals affected and their families. Because the incidence of DS remains at approximately one in 700 live births and the life span is now >...
Spremljeno u:
| Glavni autor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2009
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2815198/ https://ncbi.nlm.nih.gov/pubmed/19963286 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tips.2009.10.010 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|